A Blend of Science and Software

Our Mission is to provide funding and support for therapeutics and devices that utilize trained Artificial Intelligence (AI) and Machine Learning (ML) to aid in diagnosis and decision making.

Investment

Identification and investment in high value pharmaceuticals and devices.

Market Focus

Market focus includes Neuroscience (Parkinson's Disease) and Imaging (Contrast Agents).

Capital

Providing Capital and Co-Investment.

Intellectual Property

Experience with Identifying and lcensing of technologies from university and/or government sponsored research.

Bringing Ideas to Life

Support and encourage the development of AI/ML software to complement the clinical and commercial utility of the asset.

Supporting Early-Stage Life Science Companies

Meritage Technologies can provide entrepreneurs with the essential support to establish a robust technical and business platform. We possess significant experience in pharmaceutical research and development encompassing injectable, oral, and diagnostic medical products, business development, and start-up management. Furthermore, in addition to seed investment, the company maintains an extensive network that provides contract services, including business development and licensing, grant writing, clinical trials, manufacturing, and regulatory affairs.

Why Choose Us?

Passion & Commitment
Honesty & Openness
Dedicated Team
Practical Approach

Our Team

BA - Hastings College BS - Pharmacy, U. of Nebraska MBA - Roosevelt University

Industry experience: Abbott Laboratories, LyphoMed, and Cary Pharmaceuticals
Douglas D. Cary, Principal
BBA - Marketing, U. of Iowa;
MBA - U. of Maryland

Industry experience: GlaxoSmithKline, Cary Pharmaceuticals, and Handa Pharma
Stephen D. Cary, Principal

We provide management expertise and seed investment to de-risk select projects in order to advance human clinical trials and strategic partnerships.

Send us a message